Reset: Enhancing Weight Loss in a Digital Intervention
Launched by STANFORD UNIVERSITY · Jun 15, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called Reset, is studying different ways to help adults lose weight using a fully digital program. The study focuses on four key eating habits: cutting back on high-calorie, low-nutrition foods (called Red Zone Foods), limiting the times of day when you eat, eating more protein, and eating more fiber. Participants will set goals, track their progress every day, and receive personalized feedback to support these habits. The program lasts 12 weeks, and everything is done remotely, so participants can take part from home using their smartphone and personal scale.
Adults who are overweight or have obesity, live in the U.S., and want to lose weight through lifestyle changes may be eligible. To join, you need to be 18 or older, have a body mass index (BMI) between 25 and 45, and have daily access to a scale, email, and a smartphone. People who are pregnant, recently lost a lot of weight, or are using weight loss medications may not qualify. During the study, participants will weigh themselves daily, complete weekly lessons about healthy eating and physical activity, and fill out surveys at the start, after one month, and at the end of the 12 weeks. The goal is to figure out which combination of these eating habits helps people lose the most weight in a safe and effective way.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adults (ages 18+ years)
- • body mass index (BMI) 25.0 to 45.0 kg/m\^2
- • smartphone ownership
- • daily access to a personal scale
- • daily access to a personal email account
- • English language proficiency
- • interest in losing weight through behavioral strategies
- • living in the United States
- Exclusion Criteria:
- • concurrent enrollment in another weight management intervention
- • loss of ≥5% body weight in the past 6 months
- • current use of a weight loss or anti-obesity medication
- • prior or planned bariatric surgery in the next 3 months
- • current pregnancy, planned pregnancy in the next 3 months, or recent pregnancy in the past 6 months
- • current breastfeeding or lactating
- • living with someone else participating in the study
- • hospitalization for a mental health condition in the past 12 months
- • inability to engage in moderate forms of physical activity akin to brisk walking
- • if weight loss is contraindicated or might be impacted by a condition (e.g., end stage renal disease, cancer, schizophrenia, dementia) or medication (e.g., steroids, antipsychotics)
- • if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus)
- • participation in another weight loss study conducted in Dr. Patel's lab in the past 6 months
- • investigator discretion for safety reasons
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Michele L Patel, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported